Patients with Parkinson's disease (PD) and restless legs syndrome (RLS) oft
en suffer from severe sleep disruption with frequent and prolonged awakenin
gs and daytime sleepiness. Sleep disturbances gradually worsen with disease
progression, and therapy may be difficult, especially in advanced stages.
The most troublesome sleep complaints in patients with Parkinson's disease
consist of nocturnal motor problems with difficulty in turning over in bed
and painful leg cramps (Lees et al., 1988). Sleep disturbances in PD are al
so a complication of chronic levodopa therapy and are less likely to occur
with controlled-release preparations. In RLS, the main causes of night-time
problems are sensory features and motor symptoms, such as restlessness and
involuntary periodic leg movements (PLM) during sleep and wakefulness. Lev
odopa is currently considered the therapy of first choice in RLS; however,
its short half-life and associated daytime augmentation of RLS symptoms may
complicate therapy Strategies that will help to succeed in these patients
are demonstrated in case reports.